Welcome To Mast Therapeutics, Inc.
We are a publicly traded biopharmaceutical company headquartered in San Diego, California.
We are leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from
over two decades of clinical, nonclinical and manufacturing experience with purified and non-
purified poloxamers, to develop vepoloxamer, our lead product candidate, for serious or life-
threatening diseases with significant unmet needs.
Click here to view our latest press releases, SEC filings, and information about company events, media, and analyst coverage. read more